Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From 10-K--preferred stock (Note in bold)

Any wonder why the BoD fought tooth and nail to keep Brian's Preferreds vote off the Proxy

Other than explaining that Delaware Corporate Law couldn't be changed via a proxy proposal (still smiling at that concept) what else was done to deserve the florid "fought tooth and nail" description?

From memory, wasn't it also pointed out that the proposal was too vague? Corrections welcome.

.

.

.

Be well

Share
New Message
Please login to post a reply